78 related articles for article (PubMed ID: 24719252)
41. Differential activation of total and EGF receptor (EGF-R) tyrosine kinase (tyr-k) in the rectal mucosa in patients with adenomatous polyps, ulcerative colitis and colon cancer.
Malecka-Panas E; Kordek R; Biernat W; Tureaud J; Liberski PP; Majumdar AP
Hepatogastroenterology; 1997; 44(14):435-40. PubMed ID: 9164515
[TBL] [Abstract][Full Text] [Related]
42. Tissue expression of transforming growth factor-beta1 and its receptors: correlation with pathologic features and biochemical progression in patients undergoing radical prostatectomy.
Shariat SF; Menesses-Diaz A; Kim IY; Muramoto M; Wheeler TM; Slawin KM
Urology; 2004 Jun; 63(6):1191-7. PubMed ID: 15183988
[TBL] [Abstract][Full Text] [Related]
43. N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer.
Melotte V; Lentjes MH; van den Bosch SM; Hellebrekers DM; de Hoon JP; Wouters KA; Daenen KL; Partouns-Hendriks IE; Stessels F; Louwagie J; Smits KM; Weijenberg MP; Sanduleanu S; Khalid-de Bakker CA; Oort FA; Meijer GA; Jonkers DM; Herman JG; de Bruïne AP; van Engeland M
J Natl Cancer Inst; 2009 Jul; 101(13):916-27. PubMed ID: 19535783
[TBL] [Abstract][Full Text] [Related]
44. Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma.
Daniel P; Wagrowska-Danilewicz M; Danilewicz M; Stasikowska O; Malecka-Panas E
Int J Colorectal Dis; 2007 Oct; 22(10):1165-72. PubMed ID: 17394006
[TBL] [Abstract][Full Text] [Related]
45. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
46. Genetic variants in the TGFβ-signaling pathway influence expression of miRNAs in colon and rectal normal mucosa and tumor tissue.
Slattery ML; Trivellas A; Pellatt AJ; Mullany LE; Stevens JR; Wolff RK; Herrick JS
Oncotarget; 2017 Mar; 8(10):16765-16783. PubMed ID: 28061442
[TBL] [Abstract][Full Text] [Related]
47. Effects of supplemental vitamin D and calcium on markers of proliferation, differentiation, and apoptosis in the normal colorectal mucosa of colorectal adenoma patients.
Gao Y; Um CY; Fedirko V; Rutherford RE; Seabrook ME; Barry EL; Baron JA; Bostick RM
PLoS One; 2018; 13(12):e0208762. PubMed ID: 30557404
[TBL] [Abstract][Full Text] [Related]
48. Long-term use of lithium and risk of colorectal adenocarcinoma: a nationwide case-control study.
Pottegård A; Ennis ZN; Hallas J; Jensen BL; Madsen K; Friis S
Br J Cancer; 2016 Mar; 114(5):571-5. PubMed ID: 26867160
[TBL] [Abstract][Full Text] [Related]
49. Genetic variation in the transforming growth factor-β-signaling pathway, lifestyle factors, and risk of colon or rectal cancer.
Slattery ML; Lundgreen A; Wolff RK; Herrick JS; Caan BJ
Dis Colon Rectum; 2012 May; 55(5):532-40. PubMed ID: 22513431
[TBL] [Abstract][Full Text] [Related]
50. Paracrine action of transforming growth factor-alpha in rectal crypt epithelium of humans.
Cameron IL; Hardman WE
Cell Biol Int; 2002; 26(12):1029-34. PubMed ID: 12468378
[TBL] [Abstract][Full Text] [Related]
51. Nuclear texture measurements in normal colorectal glands.
Hamilton PW; Bartels PH; Wilson RH; Sloan JM
Anal Quant Cytol Histol; 1995 Dec; 17(6):397-405. PubMed ID: 8750354
[TBL] [Abstract][Full Text] [Related]
52. Individuals with a strong family history of colorectal cancer demonstrate abnormal rectal mucosal proliferation.
Rooney PS; Robinson MH; Clarke PA; Hardcastle JD; Armitage NC
Br J Surg; 1993 Feb; 80(2):249-51. PubMed ID: 8443673
[TBL] [Abstract][Full Text] [Related]
53. Large-bowel mucosal biotransformation activity in persons at high risk for colorectal cancer. A preliminary report.
Tobi M; Darmon E; Rozen P; Avigdor S; Rattan J; Santo M; Barnea ER
Scand J Gastroenterol; 1993 Nov; 28(11):958-62. PubMed ID: 8284630
[TBL] [Abstract][Full Text] [Related]
54. Epigenetic Targeting of Transforming Growth Factor β Receptor II and Implications for Cancer Therapy.
Chowdhury S; Ammanamanchi S; Howell GM
Mol Cell Pharmacol; 2009 Jan; 1(1):57-70. PubMed ID: 20414468
[TBL] [Abstract][Full Text] [Related]
55. An evaluation of rectal epithelial proliferation measurement as biomarker of risk for colorectal neoplasia and response in intervention studies.
Rozen P
Eur J Cancer Prev; 1992 Apr; 1(3):215-24. PubMed ID: 1467766
[TBL] [Abstract][Full Text] [Related]
56. Identification of patients at high risk for colorectal carcinoma from biopsy studies of the apparently normal colorectal mucosa. A multivariate analysis.
Sandforth F; Witzel L; Balzer T; Gutschmidt S; Janicke I; Riecken EO
Eur J Clin Invest; 1991 Jun; 21(3):295-302. PubMed ID: 1909633
[TBL] [Abstract][Full Text] [Related]
57. Cell exfoliation in the human colon: myth, reality and implications for colorectal cancer screening.
Loktionov A
Int J Cancer; 2007 Jun; 120(11):2281-9. PubMed ID: 17351899
[TBL] [Abstract][Full Text] [Related]
58. Changing site distribution of colorectal cancer.
Kee F; Wilson RH; Gilliland R; Sloan JM; Rowlands BJ; Moorehead RJ
BMJ; 1992 Jul; 305(6846):158. PubMed ID: 1515832
[No Abstract] [Full Text] [Related]
59. Colorectal cancer: a tale of two sides or a continuum?
Yamauchi M; Lochhead P; Morikawa T; Huttenhower C; Chan AT; Giovannucci E; Fuchs C; Ogino S
Gut; 2012 Jun; 61(6):794-7. PubMed ID: 22490520
[No Abstract] [Full Text] [Related]
60. Two Sides of the Same Coin: The Roles of Transforming Growth Factor-β in Colorectal Carcinogenesis.
Feng Y; Pauklin S
Gastroenterology; 2020 Jul; 159(1):397-398. PubMed ID: 32234301
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
